Medtronic plc (MDT) FY2025 Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-10-26 to 2025-01-24

Swipe to see the full flow
Medtronic plc cash flow reconciliation, Oct 26, 2024 through Jan 24, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $1,303,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $684,000,000.00Accounts payable and accrued liabilities → Operating adjustments reconciliation: $550,000,000.00Other operating assets and liabilities → Operating adjustments reconciliation: $115,000,000.00Other, net → Operating adjustments reconciliation: $112,000,000.00Stock-based compensation → Operating adjustments reconciliation: $98,000,000.00Provision for credit losses → Operating adjustments reconciliation: $51,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $1,269,000,000.00Operating adjustments reconciliation → Inventories: $200,000,000.00Operating adjustments reconciliation → Deferred income taxes: $138,000,000.00Operating adjustments reconciliation → Accounts receivable, net: $3,000,000.00Sales and maturities of investments → investing reconciliation: $1,917,000,000.00investing reconciliation → Purchases of investments: $2,074,000,000.00investing reconciliation → Additions to property, plant, and equipment: $476,000,000.00investing reconciliation → Other investing activities, net: $112,000,000.00investing reconciliation → Acquisitions, net of cash acquired: $98,000,000.00Net cash used in financing activities → financing reconciliation: $1,753,000,000.00Issuance of ordinary shares → financing reconciliation: $168,000,000.00Other financing activities, net → financing reconciliation: $160,000,000.00financing reconciliation → Change in current debt obligations, net: $1,003,000,000.00financing reconciliation → Dividends to shareholders: $897,000,000.00financing reconciliation → Repurchase of ordinary shares: $181,000,000.00Net cash used in investing activities → investing reconciliation: $843,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,394,000,000.00Net cash from operating activities → Cash sources and uses: $2,572,000,000.00Cash sources and uses → Exchange-rate effect: $130,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $1,240,000,000.00Cash sources and uses → Net cash used in investing activities: $843,000,000.00Cash sources and uses → Net cash used in financing activities: $1,753,000,000.00Accounts receivable, net: -$3,000,000.00Accounts & notes receivable−$3.00 MStock-based compensation: $98,000,000.00Stock-based compensation+$98.00 MDepreciation and amortization: $684,000,000.00Depreciation & amortization+$684.00 MNet income: $1,303,000,000.00Net income+$1.30 BProvision for credit losses: $51,000,000.00Credit loss provision+$51.00 MOther operating assets and liabilities: $115,000,000.00Other working capital, net+$115.00 MDeferred income taxes: -$138,000,000.00Deferred taxes & credits−$138.00 MInventories: -$200,000,000.00Inventories−$200.00 MOther, net: $112,000,000.00Other non-cash items+$112.00 MAccounts payable and accrued liabilities: $550,000,000.00Payables & accrued liabilities+$550.00 MNet cash from operating activities: $2,572,000,000.00Operating cash+$2.57 BOperating adjustments reconciliation: $1,610,000,000.00Change in current debt obligations, net: -$1,003,000,000.00Short-term debt ≤3 months, net−$1.00 BDividends to shareholders: -$897,000,000.00Common dividends paid−$897.00 MOther financing activities, net: $160,000,000.00Other financing, net+$160.00 MIssuance of long-term debt: $0.00Repurchase of ordinary shares: -$181,000,000.00Common stock repurchases−$181.00 MIssuance of ordinary shares: $168,000,000.00Equity issued+$168.00 MNet cash used in financing activities: -$1,753,000,000.00. Cash required to fund net payments.Financing cash−$1.75 Bfinancing reconciliation: $2,081,000,000.00Additions to property, plant, and equipment: -$476,000,000.00PP&E purchases−$476.00 MSales and maturities of investments: $1,917,000,000.00Investment sales & maturities+$1.92 BPurchases of investments: -$2,074,000,000.00Investment purchases−$2.07 BOther investing activities, net: -$112,000,000.00Other investing, net−$112.00 MAcquisitions, net of cash acquired: -$98,000,000.00Acquisitions, net of cash−$98.00 MNet cash used in investing activities: -$843,000,000.00. Cash required to fund net payments.Investing cash−$843.00 Minvesting reconciliation: $2,760,000,000.00Cash sources and uses: $3,966,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,394,000,000.00Beginning cash$1.39 BEnding cash: Cash, cash equivalents, and restricted cash: $1,240,000,000.00Ending cash$1.24 BExchange-rate effect: -$130,000,000.00FX effect−$130.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$2.10 BOperating cash − cash spent on PP&ECash flow / Net income1.97×Operating cash flow ÷ net incomeNet cash change−$154.00 MEnding cash − beginning cash
Chart details

Medtronic plc cash flow reconciliation, Oct 26, 2024 through Jan 24, 2025

Cash flows for Oct 26, 2024 through Jan 24, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Oct 25, 2024. Ending cash: Jan 24, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Oct 25, 2024
1,394,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
2,572,000,000 US dollars. Net cash provided.
Accounts receivable, net
negative 3,000,000 US dollars
Stock-based compensation
98,000,000 US dollars
Depreciation and amortization
684,000,000 US dollars
Net income
1,303,000,000 US dollars
Provision for credit losses
51,000,000 US dollars
Other operating assets and liabilities
115,000,000 US dollars
Deferred income taxes
negative 138,000,000 US dollars
Inventories
negative 200,000,000 US dollars
Other, net
112,000,000 US dollars
Accounts payable and accrued liabilities
550,000,000 US dollars
Investing activities
negative 843,000,000 US dollars. Net cash used.
Additions to property, plant, and equipment
negative 476,000,000 US dollars
Sales and maturities of investments
1,917,000,000 US dollars
Purchases of investments
negative 2,074,000,000 US dollars
Other investing activities, net
negative 112,000,000 US dollars
Acquisitions, net of cash acquired
negative 98,000,000 US dollars
Financing activities
negative 1,753,000,000 US dollars. Net cash used.
Change in current debt obligations, net
negative 1,003,000,000 US dollars
Dividends to shareholders
negative 897,000,000 US dollars
Other financing activities, net
160,000,000 US dollars
Issuance of long-term debt
0 US dollars
Repurchase of ordinary shares
negative 181,000,000 US dollars
Issuance of ordinary shares
168,000,000 US dollars
Operating adjustment reconciliation
1,610,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
2,081,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
2,760,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 130,000,000 US dollars
Ending cash on Jan 24, 2025
1,240,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
3,966,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 154,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.97×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
2,572,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
476,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
2,096,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $1.27B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 2,572,000,000 US dollars minus 476,000,000 US dollars equals 2,096,000,000 US dollars.
Medtronic plc (MDT) FY2025 Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!